Clinical trial
A Phase 2/3 Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Major Depressive Disorder
NCT04832425 is registered in ClinicalTrials.gov with Praxis Precision Medicines as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2/3 Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Major Depressive Disorder
- Lead sponsor
- Praxis Precision Medicines
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- March 30, 2021
- Completion date
- May 5, 2022
- Enrollment
- 216 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.